| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 47.1718 | 37 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.267 | 28 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.531 | 20 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.183 | 23 |
| GSM780720 | Untreated after 4 days (C2_2) | 46.2428 | 33 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.1701 | 33 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 44.2238 | 23 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.5453 | 25 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.655 | 30 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 50.1589 | 49 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 49.3269 | 46 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 38.0452 | 3 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 43.9247 | 22 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.5561 | 35 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.1802 | 23 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.8135 | 26 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 41.4932 | 11 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.8503 | 31 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.2752 | 23 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 47.9889 | 41 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 41.2339 | 10 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.4308 | 39 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 43.6874 | 21 |